v3.25.2
SHARE-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense resulting from equity awards included in the Company’s condensed consolidated statements of operations:

 

   2025   2024   2025   2024 
   For the Three Months Ended
June 30,
  

For the Six Months Ended

June 30,

 
   2025   2024   2025   2024 
General and Administrative  $-   $9,643   $-   $79,374 
Sales and Marketing   -    125    -    1,472 
Development   -    890    -    (1,997)
Stock-based compensation expense  $-   $10,658   $-   $78,849 
SCHEDULE OF CALCULATION WEIGHTED AVERAGE DILUTIVE COMMON SHARES

The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

 

   For the Three and Six Months Ended 
   June 30, 
   2025   2024 
Stock options (1)   96,828    97,919 
Warrants (2)   33,574    33,574 
    130,402    131,493 

 

(1) Represents all outstanding stock options as of June 30, 2025. The weighted average exercise price for anti-dilutive options was $61.76 for the three and six months ended June 30, 2025, respectively.
(2) Represents all outstanding warrants as of June 30, 2025, excluding the Pre-Funded Warrant. The exercise price for the warrants range from $21.74 to $29.38.